Update shared on19 Sep 2025
Fair value Increased 7.05%Analysts have revised their outlook upward for Yatharth Hospital & Trauma Care Services, driven by higher forecasts for both future P/E and revenue growth, resulting in an increased consensus price target from ₹780.00 to ₹835.00.
What's in the News
- Board approved entering a binding term sheet to acquire 100% of Shantived Institute of Medical Sciences at an enterprise value of INR 2,600 million.
- Statutory auditor, M/s. R Nagpal Associates, resigned; MAPPS & Company to step in.
- Board meeting scheduled to approve Q1 FY26 unaudited financial results.
- Corporate office relocated to Sovereign Capital Gate, Noida.
- Inaugurated new 300-bed super speciality hospital in Model Town, New Delhi, expanding bed capacity and strengthening presence in NCR.
Valuation Changes
Summary of Valuation Changes for Yatharth Hospital & Trauma Care Services
- The Consensus Analyst Price Target has risen from ₹780.00 to ₹835.00.
- The Future P/E for Yatharth Hospital & Trauma Care Services has risen from 39.74x to 41.92x.
- The Consensus Revenue Growth forecasts for Yatharth Hospital & Trauma Care Services has risen slightly from 32.0% per annum to 33.1% per annum.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.